{
    "SPADE_N_13776": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13776",
            "Peptide Name": "To-KL37 (cathelicidin, natural AMPs; mammals, animals, UCLL1c, XXA, XXE)",
            "Source": "the Iberian Mole, Spanish Mole,Talpa occidentalis",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KLFGKVGNLLQKGWQKIKNIGRRIKDFFRNIRPMQEA",
            "Sequence Length": 37,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4429.25,
            "PI": 11.6,
            "Hydrophobicity": -0.75,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Otazo-Pérez A, Asensio-Calavia P, González-Acosta S, Baca-González V, López MR, Morales-delaNuez A, Pérez de la Lastra JM.2022",
                    "Reference": "Vaccines (Basel). 2022 Jul 10;10(7):1105. doi: 10.3390/vaccines10071105.PubMed",
                    "Title": "Antimicrobial Activity of Cathelicidin-Derived Peptide from the Iberian Mole Talpa occidentalis"
                }
            ],
            "Frequent Amino Acids": "KGI",
            "Absent Amino Acids": "CHOSTUY",
            "Basic Residues": 10,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 15,
            "Polar Residues": 18,
            "Positive Residues": 10,
            "Negative Residues": 2,
            "Net Charge": 8,
            "Comments": "APD analysis reveals this sequence is most similar (53.56%) tocat FeCATHK: 16%; I=G=R=11%. Mol formula: C202H336N59O48S1; Mol Wt: 4429.297; Mol Ex Coeff: 5550; GRAVY:  -0.7516.Discovery: Identified via homologous sequence alignment with the conserved “cathelin” domain”.Chemical modification:  the N-terminus of the synthetic peptide is acetylated (XXE) while the C-terminus is amidated (XXA). Whether these modifications occur in the natural form remain established.Activity: Active against E. coli CECT 434 (MIC 6.25-12.5 uM), S. aureus CECT 794 (MIC 6.25–3.13 uM), C. jejuni CECT 9112 (MIC 1.56–0.78 uM), S. enterica CECT 456 (MIC 6.25–3.13 uM), and P. aeruginosa CECT 108 (MIC 25–12.5 uM).Toxicity:  16% hemolysis at 50 uM.Structure: predicted to be helical. Registered 8/2022",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02242",
                    "Similarity": 0.5454545454545454,
                    "Sequence": "QLGDVLQKAGEKIVRGLKNIGQRIKDFFGKLTPRTES"
                }
            ]
        }
    }
}